Shared Care Agreements

Shropshire CCG Effective Shared Care Agreements

Amiodarone ESCA - December 2014 [pdf] 204KB

Apomorphine SCA.pdf [pdf] 379KB

Azathioprine for non-rheumatology indications ESCA - December 2014 [pdf] 231KB

Azathioprine Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 [pdf] 238KB (co-developed with RJAH)

Ciclosporin oral for dermatology indications ESCA - December 2014 [pdf] 242KB

Ciclosporin Oral Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 [pdf] 251KB (co-developed with RJAH)

D-Penicillamine Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 [pdf] 305KB (co-developed with RJAH)

Denosumab SCA v 4.pdf [pdf] 387KB

Dronedarone ESCA - December 2014 [pdf] 201KB

Leflunomide Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 [pdf] 248KB (co-developed with RJAH)

Methotrexate for dermatological indications ESCA - December 2014 [pdf] 269KB

Methotrexate Oral and Parenteral Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015.pdf [pdf] 394KB  (co-developed with RJAH)

Riluzole Effective Shared Care Agreement for patients with amyotrophic lateral sclerosis - November 2013 [pdf] 113KB

Sodium aurothiomalate (Gold therapy) Rheumatology Local Safety Monitoring Schedule for Shared Care - May 2015 [pdf] 246KB (co-developed with RJAH)

Somatropin (recombinant Human Growth Hormone) treatment in adults.pdf [pdf] 204KB

Sulfasalazine for gastroenterological indications ESCA - December 2014 [pdf] 225KB

Sulfasalazine Rheumatology Local Safety Monitoring Schedule for Shared Care - August 2015[pdf] 293KB (co-developed with RJAH)

 

Mental Health Effective Shared Care Agreements

Access Effective Shared Care Agreements on South Staffordshire and Shropshire Healthcare NHS Foundation Trust's website

Drug Formulary

Click the links below to read the drug formulary information on these sections: